Raymond James Trust’s ARK Genomic Revolution ETF ARKG Stock Holding History

Raymond James Trust’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-11,282	Closed	-$385K	–	1157
2023 Q2	$385K	Hold	11,282	–	–	0.01%	777
2023 Q1	$339K	Hold	11,282	–	–	0.01%	808
2022 Q4	$318K	Buy	+11,282	New	+$358K	0.01%	791
2022 Q2	–	Sell	-5,731	Closed	-$263K	–	1089
2022 Q1	$263K	Buy	5,731 +362	+7%	+$17.3K	0.01%	950
2021 Q4	$329K	Sell	5,369 -249	-4%	-$17.2K	0.01%	854
2021 Q3	$420K	Buy	5,618 +1,934	+52%	+$162K	0.01%	689
2021 Q2	$341K	Buy	3,684 +550	+18%	+$46.8K	0.01%	797
2021 Q1	$278K	Buy	+3,134	New	+$311K	0.01%	860

Other funds holding ARKG

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $49.6B AUM 39.59% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

MMEA

Main Management ETF Advisors San Francisco, California $3.3B AUM 33.88% 1-Year Est. Return

Raymond James Trust's ARKG Position: Q3 2023 in Review

Raymond James Trust sold out of ARK Genomic Revolution ETF (ARKG) in Q3 2023, closing a stake of 11,282 shares — an estimated $385K sold.

Raymond James Trust first reported a position in ARKG in Q1 2021 and held it in 8 quarters. The position peaked at $420K in Q3 2021. 288 funds tracked by Wall St. Rank hold ARKG as of Q3 2023.

Raymond James Trust reported no remaining ARK Genomic Revolution ETF position as of Q3 2023 after selling out during the quarter.
Raymond James Trust sold 11,282 ARK Genomic Revolution ETF shares in Q3 2023, an estimated $385K.
Raymond James Trust first reported a position in ARK Genomic Revolution ETF in Q1 2021 and held it in 8 quarters.
Raymond James Trust's ARK Genomic Revolution ETF position peaked at $420K in Q3 2021.
288 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q3 2023.

Based on Raymond James Trust's 13F filing for Q3 2023, filed 14 Nov 2023.